Literature DB >> 22087551

The impact and management of nonmotor symptoms of Parkinson's disease.

Kelly E Lyons1, Rajesh Pahwa.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder diagnosed by the presence of bradykinesia and at least 1 of the symptoms of rigidity, resting tremor, or postural instability. It is increasingly recognized that nonmotor symptoms are common and can adversely affect quality of life, yet they often are not diagnosed and consequently are often untreated. Nonmotor symptoms include neuropsychiatric issues such as anxiety, depression, hallucinations, impulse control disorders, and cognitive impairment, as well as autonomic dysfunction, which may present as gastrointestinal, urinary, and sexual disturbances. Nonmotor symptoms also include excessive sweating, orthostatic hypotension, and sleep disturbances. Management of PD requires recognition of both motor and nonmotor symptoms as well as an understanding of the relationship between these symptoms and how they can be affected by treatments for PD. Therapy should be individualized for each patient, as treatments for the motor symptoms of PD can improve some nonmotor symptoms while they can worsen others. In many cases, symptom-specific treatments are necessary to control nonmotor symptoms of PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22087551

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  15 in total

1.  Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Authors:  Jacob K Akintunde; C Abigail Irechukwu
Journal:  Ther Adv Drug Saf       Date:  2016-07-22

Review 2.  Closing the loop for patients with Parkinson disease: where are we?

Authors:  Hazhir Teymourian; Farshad Tehrani; Katherine Longardner; Kuldeep Mahato; Tatiana Podhajny; Jong-Min Moon; Yugender Goud Kotagiri; Juliane R Sempionatto; Irene Litvan; Joseph Wang
Journal:  Nat Rev Neurol       Date:  2022-06-09       Impact factor: 44.711

3.  Learning on Jupiter, learning on the Moon: the dark side of the G-force. Effects of gravity changes on neurovascular unit and modulation of learning and memory.

Authors:  Yves Porte; Jean-Luc Morel
Journal:  Front Behav Neurosci       Date:  2012-09-24       Impact factor: 3.558

Review 4.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

5.  Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson's Disease I-III H&Y Stage.

Authors:  A A Pilipovich; O V Vorob'eva; S A Makarov; N N Shindryaeva; Yu D Vorob'eva
Journal:  Parkinsons Dis       Date:  2022-04-28

6.  Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study.

Authors:  Kandadai Rukmini Mridula; Rupam Borgohain; Shaik Afshan Jabeen; Gaddamanugu Padmaja; Vcs Srinivasarao Bandaru; Praveen Ankathi; Meena A Kanikannan; Mohammed Shujath Ali Khan
Journal:  Iran J Neurol       Date:  2015-04-04

7.  Subjective poor sleep quality in Chinese patients with Parkinson's disease without dementia.

Authors:  Li Zhang; Jingde Dong; Weiguo Liu; Yingdong Zhang
Journal:  J Biomed Res       Date:  2013-05-23

Review 8.  Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Authors:  Seyed-Mohammad Fereshtehnejad; Johan Lökk
Journal:  Parkinsons Dis       Date:  2014-02-02

9.  Outcomes After Non-neurological Surgery in Patients With Parkinson's Disease: A Nationwide Matched Cohort Study.

Authors:  Yu-Feng Huang; Yi-Chun Chou; Chun-Chieh Yeh; Chaur-Jong Hu; Yih-Giun Cherng; Ta-Liang Chen; Chien-Chang Liao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Non-motor symptoms of Parkinson's disease: the patient's perspective.

Authors:  Kieran C Breen; Gerda Drutyte
Journal:  J Neural Transm (Vienna)       Date:  2012-12-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.